Trial intelligence / Profile preview

Soventol Hydrocortisone Acetate 1% Cremogel vs vehicle in mild eczema or dermatitis

2017-000984-34Phase 2Completed

Sponsor
Medice
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of hydrocortisone in atopic dermatitis (AD), seborrheic dermatitis (SD) and Stasis Dermatitis (SD), sponsored by Medice. Started Oct 2017; status: completed.

02

Drugs

hydrocortisone
03

Conditions

atopic dermatitis (AD)seborrheic dermatitis (SD)Stasis Dermatitis (SD)

Beyond the preview

Go deeper on 2017-000984-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000984-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call